Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2630-2632

  Li, Yong mei ^a   Guo, Yue ping ^a   Liu, Yan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac stem cells; Cardiotoxicity; Chemotherapy; Hypothesis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; HEART DISEASE; HUMAN; NEOPLASM; STEM CELL;

ANTINEOPLASTIC AGENTS; HEART DISEASES; HUMANS; NEOPLASMS; STEM CELLS;

EID: 78649693343     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01177.x     Document Type: Article

References (12)

1. Jensen BV. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. Semin Oncol. 2006; 33: S15-21.
2. Huddart RA, Norman A, Shahidi M, et al Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol. 2003; 21: 1513-23.
3. Dolci A, Dominici R, Cardinale D, et al Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008; 130: 688-95.
4. Bearzi C, Rota M, Hosoda T, et al Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007; 104: 14068-73.
5. Gonzalez A, Rota M, Nurzynska D, et al Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008; 102: 597-606.
6. Bergmann O, Bhardwaj RD, Bernard S, et al Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-102.
7. De Angelis A, Piegari E, Cappetta D, et al Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation. 2010; 121: 276-92.
8. Garber K. The second wave in kinase cancer drugs. Nat Biotechnol. 2006; 24: 127-30.
9. Garcia-Alvarez A, Garcia-Albeniz X, Esteve J, et al. Cardiotoxicity of tyrosine-kinase-targeting drugs. Cardiovasc Hematol Agents Med Chem. 2010; 8: 11-21.
10. Cheng H, Force T. Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ Res. 2010; 106: 21-34.
11. Reya T, Morrison SJ, Clarke MF, et al Stem cells, cancer, and cancer stem cells. Nature. 2001; 414: 105-11.
12. Cohen ED, Tian Y, Morrisey EE. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development. 2008; 135: 789-98.